This article outlines a simple method for esti mating the degree of cerebral atrophy and subsequent ex perimental control for the effects of cerebral atrophy on regional metabolic values measured with positron emis sion tomography, It is suggested that rather than cor recting derived values for atrophy, less potential error is introduced by experimentally controlling for regional at-
reviewed the problem of delineating true reductions in tissue metabolic rates from apparent reductions in these values as a result of cerebral atrophy in metabolic data derived from positron emission tomography (PET), In addition, they described a quantitative procedure for cor recting global CBF, CMR02, and cerebral blood volume estimates for cerebral atrophy, Subse quently, Strother and Rottenberg (1986) outlined a number of potential and, as yet, unevaluated error sources in the proposed correction procedure, They concluded that "inappropriate use of globally derived correction factors may increase, rather than reduce, the error in PET measurements of CBF and metabolism." A further problem with any correction procedure is validation. For example, Herscovitch et aL (1986) did illustrate the effect of the proposed correction technique on data derived from young normals, aged normals, and patients with the provisional diagnosis of Alzheimer's dis-rophy when possible, By treating the derived metabolic rates and the measure of atrophy as two separate vari ables, it is also possible to establish whether there actu ally is a demonstrable relationship between the two mea sures, Key Words: Aging-Cerebral Atrophy -Cerebral Metabolism-Huntington's Chorea-Positron Emission To mography, ease. As expected, the greater the degree of mea sured cerebral atrophy, the greater the correction effect on CBF, CMR02, and cerebral blood volume. However, there is no assurance that these corrected values are better estimates of the true values than the uncorrected values, as the true values are unknown. Comparing the corrected and uncorrected values with a technique that is inde pendent of cerebral atrophy, such as the Kety Schmidt method (Kety and Schmidt, 1948) , would be the appropriate way for determining if the cor rected values are better estimates of the true values than the uncorrected values.
An alternative approach is to attempt to control for cerebral atrophy by applying specific selection criteria. For example, in our studies of patients with Huntington's chorea and those at risk for Huntington's disease (Hayden et aI., 1986) , esti mates of caudate atrophy are derived directly from cranial computerized tomography (CT) and com pared to those obtained on a normal sample. By using a simple regression procedure, it is possible to determine if the degree of measured caudate at rophy is consistent with the subject's age. Once such a determination is made, the researcher has a number of choices in terms of experimental con troL For example, rather than age matching one may wish to match in terms of degree of atrophy.
The purpose of this article is to outline this method and to illustrate its utility in clinical research.
MATERIALS AND METHODS
Data from CT scans on 69 subjects (20 men, 49 women) aged 14-78 years, with no neurological signs or symptoms or cerebral pathology, were used to define normal or expected variation. All CT scans were done on a Siemens Somaton DR2 whole body scanner with a slice thickness of 8 mm and slice interval of 8 mm. For each subject, the shortest distance between the heads of the caudate nuclei (CC) and the greatest distance between the frontal horns (FH) were measured as shown in Fig. I . The ratio of these two measures was then calculated (i.e., CC/FH). As neither the distribution of age nor the CC/FH ratio were significantly different from the normal distribution (Kolmogorov-Smirnov test of normality), age and the CC/FH ratio were correlated using a Pearson product-moment correlation. These data are summarized in Ta ble 1.
The strong positive correlation (0.55) between age and the CC/FH ratio suggests that one can expect significant increases in this ratio with normal aging. The actual re gression line for this relationship between the CC/FH ratio and age is plotted in Fig. 2 . The regression line is bound by ± 2 standard errors of prediction, and this bound was defined as normal variation. As expected, for the 69 normal subjects, two fe ll outside this bound. From this figure, it is apparent that a CC/FH ratio of 0.45 is within normal limits for a 65-year-old individual, but is abnormal for a 20-year-old.
With respect to the research application of the method, 
DISCUSSION
Logistically, the outlined procedure is consider ably simpler than the one proposed by Herscovitch et al. (1986) , it avoids the potential error propoga tion as reviewed by Strother and Rottenberg (1986) , and it is not restricted to global estimates. How ever, one must determine a reliable and appropriate measure of regional cerebral atrophy for the dis ease of interest. Fortunately, for our studies, the CC/FH ratio was already a recommended and vali dated neuroradiological marker of Huntington's disease and had been shown to increase with normal aging (Scheibel and Scheibel, 1975; Kohl meyer, 1982 , Stober et aI. , 1984 Hayden et aI. , 1986) . Once the regression line was plotted for the 69 normal subjects, the degree of caudate atrophy for an individual could be rapidly assessed visually by using Fig. 2 .
This procedure can also address whether or not the actual atrophy does affect regional metabolic rates. Simplistically, the magnitude of the potential relationship between regional metabolism and at rophy is dependent on the ratio of the size of the region of interest (as dictated by the resolution of the scanner) and the size of the structure of interest (as dictated by neuroanatomical development or degeneration). In theory, if the structure of interest is considerably larger than the region of interest, the effect of specific types of cerebral atrophy on regional rates may be minimal. As the outlined pro cedure yields a quantitative measure of regional at rophy, it is possible to correlate this measure with the observed metabolic rate. If there is no relation ship between the degree of atrophy and the mea sured metabolic rate, then cerebral atrophy is not affecting the measured values. If a relationship is found, then a matching or selective sampling proce dure can be employed to rule out the confounding effects of atrophy.
In conclusion, in the method proposed by Her 
